marijuana stocks news

Form 8-K for LEXARIA CORP.


27-Apr-2016

Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of PrincipalEffective April 29, 2016, Ms. Bal Bhullar will be resigning as Chief Financial Officer and Director from Lexaria and Lexaria’s subsidiaries.

Mr. Chris Bunka will become interim Chief Financial Officer until a replacement is filled for that position once Ms. Bal Bhullar has resigned.

Effective April 29, 2016, the Board will appoint Mr. John Docherty as director of the Company.

 

Item 7.01 Regulation FD Disclosure.A copy of the news release is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No. Description

99.1 Press Release dated April 27, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc. (TBPMF) Management Provides Corporate Update

Tetra Bio-Pharma’s Management Provides Corporate Update on QIXLEEF(TM) & CAUMZ(TM) Drug Development…

Namaste Technologies Inc. (NXTTF) Reaffirms Position on No US Exposure

Namaste Reaffirms Position on No US Exposure and Provides Corporate Response to…

Curaleaf Holdings, Inc. (CURA) to Report Second Quarter 2021 Financial and Operational Results

Curaleaf to Report Second Quarter 2021 Financial and Operational Results Curaleaf Holdings,…

$PLPL Delivers on First Purchase Order of Green Tea Extract to USN

Plandai Biotechnology, Inc. Delivers on First Purchase Order of Green Tea Extract…